Wilcox and Ladabaum discussed ways to reduce risk of gastrointestinal complications of nonsteroidal anti-inflammatory agents (NSAIDS) in a patient at high risk for these complications. The authors are from the University of Alabama at Birmingham and University of California San Francisco.